Zhiheng Liu Selected Research

Zhiheng Liu Research Topics

Disease

6	Cognitive Dysfunction 03/2024 - 01/2012
6	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 01/2012
5	Pain (Aches) 04/2024 - 01/2022
5	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 01/2019
4	Inflammation (Inflammations) 04/2024 - 01/2021
3	Hyperalgesia 04/2024 - 01/2022
3	Neoplasms (Cancer) 11/2023 - 10/2021
3	Cysts 01/2023 - 01/2019
2	Sepsis-Associated Encephalopathy 03/2024 - 01/2023
2	Mucopolysaccharidosis I (Hurler Syndrome) 01/2022 - 01/2019
1	Central Nervous System Diseases (CNS Diseases) 04/2024
1	Hepatocellular Carcinoma (Hepatoma) 11/2023
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2023
1	Hemorrhage 01/2023
1	Polycystic liver disease 01/2023
1	Sepsis (Septicemia) 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Obesity 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Dyspepsia (Indigestion) 12/2022
1	Wounds and Injuries (Trauma) 11/2022
1	Acute Kidney Injury (Acute Renal Failure) 11/2022
1	Reperfusion Injury 11/2022
1	Hypersensitivity (Allergy) 11/2022
1	Clostridium Infections 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2021
1	Lung Neoplasms (Lung Cancer) 10/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Neurodevelopmental Disorders 01/2021
1	Cardiomegaly (Heart Hypertrophy) 11/2020
1	Heart Failure 11/2020
1	Delirium 01/2020
1	Myocardial Infarction 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Ischemia 01/2019

Drug/Important Bio-Agent (IBA)

3	Interleukin-6 (Interleukin 6)IBA 04/2024 - 01/2022
3	RNA (Ribonucleic Acid)IBA 11/2023 - 10/2021
3	ChromatinIBA 01/2023 - 10/2021
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2013
3	Peptides (Polypeptides)IBA 01/2022 - 01/2012
3	Amyloid (Amyloid Fibrils)IBA 03/2016 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2013
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2022
2	Iduronidase (alpha-L-Iduronidase)IBA 01/2022 - 01/2019
2	Positive Transcriptional Elongation Factor BIBA 01/2022 - 01/2019
2	Anesthetics (Anesthetic Agents)IBA 01/2021 - 10/2019
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2021 - 10/2019
2	Apolipoprotein E4IBA 03/2016 - 11/2013
2	Peptide Hydrolases (Proteases)FDA Link 11/2013 - 01/2012
2	Insulysin (Insulin-Degrading Enzyme)IBA 11/2013 - 01/2012
1	LipopolysaccharidesIBA 04/2024
1	Protein SIBA 04/2024
1	LuciferasesIBA 03/2024
1	Codon (Codons)IBA 11/2023
1	Lysine (L-Lysine)FDA Link 11/2023
1	acarboxyprothrombin (PIVKA)IBA 11/2023
1	1-dodecylpyridoxal (PLD)IBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	AcetyltransferasesIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Sirtuin 1IBA 01/2023
1	AntralIBA 12/2022
1	Canrenoic Acid (Potassium Canrenoate)IBA 11/2022
1	antineoplaston A10 (A 10)IBA 03/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2022
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 03/2022
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2022
1	AcidsIBA 01/2022
1	GlycosaminoglycansIBA 01/2022
1	3- (5- (4- (cyclopentyloxy)- 2- hydroxybenzoyl)- 2- ((3- hydroxy- 1,2- benzisoxazol- 6- yl)methoxy)phenyl)propionic acidIBA 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2022
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2022
1	LigandsIBA 11/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2021
1	dolichos biflorus agglutininIBA 10/2021
1	ImmunosorbentsIBA 01/2021
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021
1	EnzymesIBA 01/2021
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 01/2021
1	Circular RNAIBA 01/2021
1	oligomycin sensitivity-conferring protein (complex V)IBA 11/2020
1	AntioxidantsIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	AMP Deaminase (Myoadenylate Deaminase)IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020

Therapy/Procedure

2	Anesthesia 01/2021 - 01/2020
2	Therapeutics 11/2020 - 03/2007
2	General Anesthesia 01/2020 - 10/2019
1	Ligation 01/2023
1	Punctures 01/2023
1	Canes (Cane) 11/2022
1	Spinal Injections 01/2022
1	Length of Stay 01/2020